Flaws in the identity and quality of biorepository specimens produce misleading experimental data that cost research labs millions of dollars in wasted resources, and in some cases to erroneous publications that damage reputations. Given the high price of research and the current funding challenges facing many laboratories, there is greater demand on biorepositories to ensure sample integrity. Yet the biobanking process is prone to error.
Related Products
Juno
Benefit from even greater accuracy and less hands-on time with a revolutionary new system that combines preamplification and SNP genotyping into one automated process.
Biomark HD
Analyze single-cell gene expression with real-time PCR, industry-leading flexibility and consistently high-quality results on the Biomark™ HD system.
Juno 96.96 Genotyping IFC
Transform your workflow with this innovative IFC, which leverages multiple layers and advanced valve controls to achieve preamplification and SNP genotyping in one step.
Insights
Feature
Flaws in the identity and quality of biorepository specimens produce misleading experimental data that cost research labs millions of dollars in wasted resources, and in some cases to erroneous publications that damage reputations. Given the high price of research and the current funding challenges facing many laboratories, there is greater demand on biorepositories to ensure sample integrity. Yet the biobanking process is prone to error.
Feature
The chief operating officer of RUCDR Infinite Biologics at Rutgers University looks like he'd be just as comfortable on a Florida golf course as he is analyzing sample datasets. In truth, Andrew Brooks, PhD, is at ease given any opportunity to discuss the benefits of the work he and his team do to advance biobanking standards.
Media
Now more than ever, scientists understand that diseases are population-specific. To support this research, biobanks must increase the variety and number of samples they store. Unfortunately, with more samples come more opportunities for sample identification errors.
Media
The recent Mendelspod podcast series “Garbage In, Garbage Out: A New Look at Biospecimen Quality” was cosponsored by Fluidigm and provides an in-depth look at the dire state of biospecimen quality and the need for regulation and standardization.